Global HERG Screening Market Research Report—Forecast till 2027

  • Licence Type:
  • Single User - $4450
  • Multi User - $6250
  • Enterprise User - $6250

Market Dynamics According to Research Statistics, Global hERG Screening Market is anticipated to record a substantial CAGR of 13.85% during the forecast period of 2020 to 2027, to surpass USD 3,304.58 Million by 2027. The expanding novel medication endorsements and the developing pervasiveness of heart illnesses are driving the worldwide hERG screening market. Notwithstanding, the significant expense of hERG screening items is required to hamper the development of this market during the gauge time frame. In any case, undiscovered business sectors are probably going to set a rewarding chance for the development of this market soon. HERG screening is basically utilized for the medication disclosure measure. The expanding number of item dispatches is foreseen to support the interest for hERG screening in the coming years. As per the yearly report distributed by the Center for Drug Evaluation and Research (CDER), an expected 25 medications got novel medications endorsement for promoting in 2016, though 59 out of 2018. The expanding number of novel medications endorsements is required to help the medications disclosure measure that helps the hERG screening business sector to develop. Market Segmentation Global hERG Screening Market has been classified into Type into ion Channel and Application. Based on type segment, the hERG screening market, has been segmented into gene KCNH2 and mutant KCNH2. The global hERG screening market is classified, based on the ion channel, into voltage-gated ion channel, ligand-gated ion channel, and others. The application segment is divided into antiarrhythmic drugs, antipsychotics, antibiotics, and others. Regional Analysis Geographically, the Global hERG Screening Market has been categorized into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to drive the largest market of the global hERG Screening market owing to largest market share of 37.3% of the hERG screening market in 2019. The regional market has been bifurcated into North America and Latin America. North America further divided into the US and Canada. The market growth of Americas is driven by the technological development and the high prevalence of cardiac disease in the region. The European hERG screening market has been classified into Western Europe and Eastern Europe. The Western Europe hERG screening market has further been categorized into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The hERG screening market in Asia-Pacific has been divided into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa hERG screening market has been bifurcated into the Middle East and Africa. Major Players The Key Players in the Global hERG Screening Market include Charles River Laboratories, Merck KGaA, Cyprotex Limited, BSYS GmbH, Creative bioarray, Eurofins Scientific, Metrion biosciences, and Aurora Biomed. Some of the key strategies followed by players operating in the Global hERG screening market are FDA approvals, joint ventures, acquisitions, expansions, and collaborations. COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 MARKET SYNOPSIS 14 1.2 MARKET ATTRACTIVENESS ANALYSIS 15 2 MARKET INTRODUCTION 2.1 DEFINITION 16 2.2 SCOPE OF THE STUDY 16 2.3 RESEARCH OBJECTIVE 16 2.4 MARKET STRUCTURE 16 2.5 ASSUMPTIONS & LIMITATIONS 17 3 RESEARCH METHODOLOGY 3.1 DATA MINING 18 3.2 SECONDARY RESEARCH 19 3.3 PRIMARY RESEARCH 20 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21 3.5 FORECASTING TECHNIQUES 21 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 INCREASING NOVEL DRUG APPROVALS 26 4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26 4.3 RESTRAINT 27 4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27 4.4 OPPORTUNITY 28 4.4.1 UNTAPPED MARKETS 28 4.5 IMPACT OF CORONAVIRUS (COVID)-19 28 4.5.1 OVERVIEW 28 4.5.2 IMPACT ON PLAYERS 28 4.5.3 IMPACT ON CLINICAL TRIALS 28 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 29 5.1.1 R&D AND DESIGNING 29 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION 30 5.1.4 MARKETING & SALES 30 5.1.5 POST-SALES MONITORING 30 5.2 PORTER’S FIVE FORCES MODEL 30 5.2.1 BARGAINING POWER OF SUPPLIERS 31 5.2.2 BARGAINING POWER OF BUYERS 31 5.2.3 THREAT OF NEW ENTRANTS 32 5.2.4 THREAT OF SUBSTITUTES 32 5.2.5 RIVALRY 32 5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32 5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32 5.3.2 ADVENT OF PATCH CLAMP ASSAY 33 5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33 5.4 CUSTOMER NEED ANALYSIS 33 5.4.1 OVERVIEW 33 5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33 5.4.3 CAUSE AND EFFECT ANALYSIS 34 6 GLOBAL HERG SCREENING MARKET, BY TYPE 6.1 OVERVIEW 35 6.2 GENE KCNH2 36 6.3 MUTANT KCNH2 36 7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL 7.1 OVERVIEW 37 7.2 VOLTAGE-GATED ION CHANNEL 39 7.3 LIGAND-GATED ION CHANNEL 39 7.4 OTHERS 40 8 GLOBAL HERG SCREENING MARKET, BY APPLICATION 8.1 OVERVIEW 41 8.2 ANTIARRHYTHMIC 43 8.3 ANTIPSYCHOTIC 43 8.4 ANTIBIOTIC 43 8.5 OTHERS 44 9 GLOBAL HERG SCREENING MARKET, BY REGION 9.1 OVERVIEW 45 9.2 AMERICAS 47 9.2.1 NORTH AMERICA 49 9.2.1.1 US 51 9.2.1.2 CANADA 52 9.2.2 LATIN AMERICA 53 9.3 EUROPE 54 9.3.1 WESTERN EUROPE 56 9.3.1.1 GERMANY 58 9.3.1.2 FRANCE 59 9.3.1.3 UK 60 9.3.1.4 ITALY 61 9.3.1.5 SPAIN 62 9.3.1.6 REST OF WESTERN EUROPE 63 9.3.2 EASTERN EUROPE 64 9.4 ASIA-PACIFIC 65 9.4.1 CHINA 67 9.4.2 JAPAN 68 9.4.3 INDIA 69 9.4.4 AUSTRALIA 70 9.4.5 SOUTH KOREA 71 9.4.6 REST OF ASIA-PACIFIC 72 9.5 MIDDLE EAST & AFRICA 73 9.5.1 MIDDLE EAST 75 9.5.2 AFRICA 76 10 COMPETITIVE LANDSCAPE 10.1 OVERVIEW 77 10.2 MARKET RANKING ANALYSIS 77 10.3 COMPETITIVE BENCHMARKING 78 10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79 10.4.1 PARTNERSHIP 79 10.4.2 ACQUISITIONS 80 10.4.3 COLLABORATION 80 10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81 10.5.1 SALES & OPERATING PROFIT MARGIN 81 10.5.2 R&D EXPENDITURE 81 11 COMPANY PROFILES 11.1 THERMO FISHER SCIENTIFIC INC. 82 11.1.1 COMPANY OVERVIEW 82 11.1.2 FINANCIAL OVERVIEW 82 11.1.3 PRODUCTS/SERVICES OFFERED 83 11.1.4 KEY DEVELOPMENTS 83 11.1.5 SWOT ANALYSIS 83 11.1.6 KEY STRATEGIES 83 11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84 11.2.1 COMPANY OVERVIEW 84 11.2.2 FINANCIAL OVERVIEW 84 11.2.3 PRODUCTS/SERVICES OFFERED 85 11.2.4 KEY DEVELOPMENTS 85 11.2.5 SWOT ANALYSIS 86 11.2.6 KEY STRATEGIES 86 11.3 MERCK KGAA 87 11.3.1 COMPANY OVERVIEW 87 11.3.2 FINANCIAL OVERVIEW 87 11.3.3 PRODUCTS/SERVICES OFFERED 88 11.3.4 KEY DEVELOPMENTS 88 11.3.5 SWOT ANALYSIS 88 11.3.6 KEY STRATEGIES 88 11.4 EUROFINS DISCOVERX CORPORATION 89 11.4.1 COMPANY OVERVIEW 89 11.4.2 FINANCIAL OVERVIEW 89 11.4.3 PRODUCTS/SERVICES OFFERED 90 11.4.4 KEY DEVELOPMENTS 90 11.4.5 SWOT ANALYSIS 90 11.4.6 KEY STRATEGIES 91 11.5 ABCAM PLC. 92 11.5.1 COMPANY OVERVIEW 92 11.5.2 FINANCIAL OVERVIEW 92 11.5.3 PRODUCTS/SERVICES OFFERED 93 11.5.4 KEY DEVELOPMENTS 93 11.5.5 SWOT ANALYSIS 94 11.5.6 KEY STRATEGIES 94 11.6 CYPROTEX LIMITED 95 11.6.1 COMPANY OVERVIEW 95 11.6.2 FINANCIAL OVERVIEW 95 11.6.3 PRODUCTS/SERVICES OFFERED 95 11.6.4 KEY DEVELOPMENTS 95 11.6.5 SWOT ANALYSIS 96 11.6.6 KEY STRATEGIES 96 11.7 B‘SYS GMBH 97 11.7.1 COMPANY OVERVIEW 97 11.7.2 FINANCIAL OVERVIEW 97 11.7.3 PRODUCTS/SERVICES OFFERED 97 11.7.4 KEY DEVELOPMENTS 97 11.7.5 SWOT ANALYSIS 98 11.7.6 KEY STRATEGIES 98 11.8 CREATIVE BIOARRAY 99 11.8.1 COMPANY OVERVIEW 99 11.8.2 FINANCIAL OVERVIEW 99 11.8.3 PRODUCTS/SERVICES OFFERED 99 11.8.4 KEY DEVELOPMENTS 99 11.8.5 SWOT ANALYSIS 100 11.8.6 KEY STRATEGIES 100 11.9 METRION BIOSCIENCES LTD 101 11.9.1 COMPANY OVERVIEW 101 11.9.2 FINANCIAL OVERVIEW 101 11.9.3 PRODUCTS/SERVICES OFFERED 101 11.9.4 KEY DEVELOPMENTS 101 11.9.5 SWOT ANALYSIS 102 11.9.6 KEY STRATEGIES 102 11.10 AURORA BIOMED INC. 103 11.10.1 COMPANY OVERVIEW 103 11.10.2 FINANCIAL OVERVIEW 103 11.10.3 PRODUCTS/SERVICES OFFERED 103 11.10.4 KEY DEVELOPMENTS 103 11.10.5 SWOT ANALYSIS 104 11.10.6 KEY STRATEGIES 104 12 APPENDIX 12.1 REFERENCES 105 12.2 RELATED REPORTS 105

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20 TABLE 3 GLOBAL HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 36 TABLE 4 GLOBAL HERG SCREENING MARKET, FOR GENE KCNH2, BY REGION, 2017-2027 (USD MILLION) 36 TABLE 5 GLOBAL HERG SCREENING MARKET, FOR MUTANT KCNH2, BY REGION, 2017-2027 (USD MILLION) 36 TABLE 6 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 38 TABLE 7 GLOBAL HERG SCREENING MARKET, FOR VOLTAGE-GATED ION CHANNEL, BY REGION, 2017-2027 (USD MILLION) 39 TABLE 8 GLOBAL HERG SCREENING MARKET, FOR LIGAND-GATED ION CHANNEL, BY REGION, 2017-2027 (USD MILLION) 39 TABLE 9 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2017-2027 (USD MILLION) 40 TABLE 10 GLOBAL HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 42 TABLE 11 GLOBAL HERG SCREENING MARKET, FOR ANTIARRHYTHMIC, BY REGION, 2017-2027 (USD MILLION) 43 TABLE 12 GLOBAL HERG SCREENING MARKET, FOR ANTIPSYCHOTIC, BY REGION, 2017-2027 (USD MILLION) 43 TABLE 13 GLOBAL HERG SCREENING MARKET, FOR ANTIBIOTIC, BY REGION, 2017-2027 (USD MILLION) 43 TABLE 14 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2017-2027 (USD MILLION) 44 TABLE 15 GLOBAL HERG SCREENING MARKET, BY REGION, 2017–2027 (USD MILLION) 46 TABLE 16 AMERICAS: HERG SCREENING MARKET, BY REGION, 2017–2027 (USD MILLION) 47 TABLE 17 AMERICAS: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 47 TABLE 18 AMERICAS: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 48 TABLE 19 AMERICAS: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 48 TABLE 20 NORTH AMERICA: HERG SCREENING MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 49 TABLE 21 NORTH AMERICA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 49 TABLE 22 NORTH AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 50 TABLE 23 NORTH AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 50 TABLE 24 US: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 51 TABLE 25 US: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 51 TABLE 26 US: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 51 TABLE 27 CANADA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 52 TABLE 28 CANADA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 52 TABLE 29 CANADA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 52 TABLE 30 LATIN AMERICA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 53 TABLE 31 LATIN AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 53 TABLE 32 LATIN AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 53 TABLE 33 EUROPE: HERG SCREENING MARKET, BY REGION, 2017–2027 (USD MILLION) 54 TABLE 34 EUROPE: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 54 TABLE 35 EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 55 TABLE 36 EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 55 TABLE 37 WESTERN EUROPE: HERG SCREENING MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 56 TABLE 38 WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 56 TABLE 39 WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 57 TABLE 40 WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 57 TABLE 41 GERMANY: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 58 TABLE 42 GERMANY: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 58 TABLE 43 GERMANY: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 58 TABLE 44 FRANCE: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 59 TABLE 45 FRANCE: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 59 TABLE 46 FRANCE: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 59 TABLE 47 UK: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 60 TABLE 48 UK: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 60 TABLE 49 UK: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 60 TABLE 50 ITALY: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 61 TABLE 51 ITALY: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 61 TABLE 52 ITALY: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 61 TABLE 53 SPAIN: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 62 TABLE 54 SPAIN: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 62 TABLE 55 SPAIN: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 62 TABLE 56 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 63 TABLE 57 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 63 TABLE 58 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 63 TABLE 59 EASTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 64 TABLE 60 EASTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 64 TABLE 61 EASTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 64 TABLE 62 ASIA-PACIFIC: HERG SCREENING MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 65 TABLE 63 ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 65 TABLE 64 ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 66 TABLE 65 ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 66 TABLE 66 CHINA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 67 TABLE 67 CHINA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 67 TABLE 68 CHINA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 67 TABLE 69 JAPAN: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 68 TABLE 70 JAPAN: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 68 TABLE 71 JAPAN: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 68 TABLE 72 INDIA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 69 TABLE 73 INDIA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 69 TABLE 74 INDIA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 69 TABLE 75 AUSTRALIA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 70 TABLE 76 AUSTRALIA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 70 TABLE 77 AUSTRALIA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 70 TABLE 78 SOUTH KOREA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 71 TABLE 79 SOUTH KOREA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 71 TABLE 80 SOUTH KOREA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 71 TABLE 81 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 72 TABLE 82 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 72 TABLE 83 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 72 TABLE 84 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY REGION, 2017–2027 (USD MILLION) 73 TABLE 85 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 73 TABLE 86 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 74 TABLE 87 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 74 TABLE 88 MIDDLE EAST: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 75 TABLE 89 MIDDLE EAST: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 75 TABLE 90 MIDDLE EAST: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 75 TABLE 91 AFRICA: HERG SCREENING MARKET, BY TYPE, 2017-2027 (USD MILLION) 76 TABLE 92 AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2017-2027 (USD MILLION) 76 TABLE 93 AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 76 TABLE 94 TOP PLAYERS IN THE GLOBAL HERG SCREENING MARKET 77 TABLE 95 PARTNERSHIP: GLOBAL HERG SCREENING MARKET 79 TABLE 96 ACQUISITIONS: GLOBAL HERG SCREENING MARKET 80 TABLE 97 COLLABORATION: GLOBAL HERG SCREENING MARKET 80 TABLE 98 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 83 TABLE 99 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS/SERVICES OFFERED 85 TABLE 100 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY DEVELOPMENTS 85 TABLE 101 MERCK KGAA: PRODUCTS/SERVICES OFFERED 88 TABLE 102 EUROFINS DISCOVERX CORPORATION: PRODUCTS/SERVICES OFFERED 90 TABLE 103 EUROFINS DISCOVERX CORPORATION: KEY DEVELOPMENTS 90 TABLE 104 ABCAM PLC.: PRODUCTS/SERVICES OFFERED 93 TABLE 105 ABCAM PLC.: KEY DEVELOPMENTS 93 TABLE 106 CYPROTEX LIMITED: PRODUCTS/SERVICES OFFERED 95 TABLE 107 B‘SYS GMBH: PRODUCTS/SERVICES OFFERED 97 TABLE 108 CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED 99 TABLE 109 METRION BIOSCIENCES LTD: PRODUCTS/SERVICES OFFERED 101 TABLE 110 AURORA BIOMED INC.: PRODUCTS/SERVICES OFFERED 103

Related Reports

Ticagrelor Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Ticagrelor market was valued at approximately USD 1761.4 million in 2022, and is expected to reach around USD 4019.37 Million by end of 2031, growing at a CAGR of 9.6% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 103
Single user Price: $2450
Sucralfate Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Sucralfate market was valued at approximately USD 253.11 million in 2022, and is expected to reach around USD 361.73 Million by end of 2031, growing at a CAGR of 4.05% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 116
Single user Price: $2450
PSP System Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global PSP System market was valued at approximately USD 226.54 million in 2022, and is expected to reach around USD 238.82 Million by end of 2031, growing at a CAGR of 0.59% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 117
Single user Price: $2450
Vitamin D3 Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Vitamin D3 market was valued at approximately USD 553.21 million in 2022, and is expected to reach around USD 1158.41 Million by end of 2031, growing at a CAGR of 8.56% during the period 2023-2031, according to Regal Intelligence. What the Report Offer ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 107
Single user Price: $2450
Gout Drugs Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Gout Drugs market was valued at approximately USD 3240.33 million in 2022, and is expected to reach around USD 11214.63 Million by end of 2031, growing at a CAGR of 14.79% during the period 2023-2031, according to Regal Intelligence. What the Report Of ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 119
Single user Price: $2450